Assessing the optimal timing for early salvage radiation therapy in patients with prostate-specific antigen rise after radical prostatectomy

European Urology

Volumn 69, Issue 4, 2016, Pages 728-733

  Fossati, Nicola ^a   Karnes, R Jeffrey ^b   Cozzarini, Cesare ^a   Fiorino, Claudio ^a   Gandaglia, Giorgio ^a   Joniau, Steven ^c   Boorjian, Stephen A ^b   Goldner, Gregor ^d   Hinkelbein, Wolfgang ^e   Haustermans, Karin ^c   Tombal, Bertrand ^f   Shariat, Shahrokh ^d   Karakiewicz, Pierre I ^g   Montorsi, Francesco ^a   Van Poppel, Hein ^c   Wiegel, Thomas ^h   Briganti, Alberto ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b MAYO CLINIC   (United States)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^g UNIVERSITÉ DE MONTRÉAL   (Canada)

^h UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Biochemical tumour markers; Neoplasm recurrence; Prostatic neoplasms; Radiotherapy; Salvage therapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; KALLIKREIN; KALLIKREIN-RELATED PEPTIDASE 3, HUMAN;

ADULT; AGED; ARTICLE; BIOCHEMICAL RECURRENCE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER CONTROL; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; EARLY SALVAGE RADIATION THERAPY; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SALVAGE THERAPY; SEMINAL VESICLE; ADENOCARCINOMA; ADVERSE EFFECTS; BLOOD; CANCER GRADING; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSTATIC NEOPLASMS; TIME FACTOR; TIME TO TREATMENT; TREATMENT OUTCOME; TUMOR RECURRENCE; UPREGULATION;

ADENOCARCINOMA; AGED; HUMANS; KALLIKREINS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SALVAGE THERAPY; TIME FACTORS; TIME-TO-TREATMENT; TREATMENT OUTCOME; UP-REGULATION;

EID: 84959488754     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2015.10.009     Document Type: Article

References (24)

1. M.W. Kattan, J.A. Eastham, A.M. Stapleton, T.M. Wheeler, and P.T. Scardino A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer J Natl Cancer Inst 90 1998 766 771
2. A.J. Stephenson, P.T. Scardino, J.A. Eastham, and et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Natl Cancer Inst 98 2006 715 717
3. A. Heidenreich, P.J. Bastian, J. Bellmunt, and et al. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer Eur Urol 65 2014 467 479
4. NCCN clinical practice guidelines in oncology (NCCN Guidelines®): prostate cancer, version 1.2015. National Comprehensive Cancer Network Web site. http://www.nccn.org/professionals/physician-gls/pdf/prostate.pdf. Accessed April 1, 2015.
5. M.S. Katz, M.J. Zelefsky, E.S. Venkatraman, Z. Fuks, A. Hummer, and S.A. Leibel Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer J Clin Oncol 21 2003 483 489
6. A.J. Stephenson, S.F. Shariat, M.J. Zelefsky, and et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy JAMA 291 2004 1325 1332
7. A.J. Stephenson, P.T. Scardino, M.W. Kattan, and et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy J Clin Oncol 25 2007 2035 2041
8. A. Briganti, R.J. Karnes, S. Joniau, and et al. Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy Eur Urol 66 2014 479 486
9. D. Pfister, M. Bolla, A. Briganti, and et al. Early salvage radiotherapy following radical prostatectomy Eur Urol 65 2014 1034 1043
10. C.R. Pound, A.W. Partin, M.A. Eisenberger, D.W. Chan, J.D. Pearson, and P.C. Walsh Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597
11. J.A. Brockman, S. Alanee, A.J. Vickers, and et al. Nomogram predicting prostate cancer-specific mortality for men with biochemical recurrence after radical prostatectomy Eur Urol 67 2015 1160 1167
12. M.N. Simmons, A.J. Stephenson, and E.A. Klein Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy Eur Urol 51 2007 1175 1184
13. A. Pearce, R. Choo, C. Danjoux, and et al. Effect of combined treatment with salvage radiotherapy plus androgen suppression on quality of life in patients with recurrent prostate cancer after radical prostatectomy Int J Radiat Oncol Biol Phys 65 2006 78 83
14. N. Suardi, A. Gallina, G. Lista, and et al. Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy Eur Urol 65 2014 546 551
15. B.J. Trock, M. Han, S.J. Freedland, and et al. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy JAMA 299 2008 2760 2769
16. S.E. Cotter, M.-H. Chen, J.W. Moul, and et al. Salvage radiation in men after prostate-specific antigen failure and the risk of death Cancer 117 2011 3925 3932
17. T. Wiegel, G. Lohm, D. Bottke, and et al. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome-results of a retrospective study Int J Radiat Oncol Biol Phys 73 2009 1009 1016
18. J.D. Karlin, B.F. Koontz, S.J. Freedland, and et al. Identifying appropriate patients for early salvage radiotherapy after prostatectomy J Urol 190 2013 1410 1415
19. H. Geinitz, M.G. Riegel, R. Thamm, and et al. Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy Int J Radiat Oncol Biol Phys 82 2012 1930 1937
20. A. Goenka, J.M. Magsanoc, X. Pei, and et al. Long-term outcomes after high-dose postprostatectomy salvage radiation treatment Int J Radiat Oncol Biol Phys 84 2012 112 118
21. A. Siegmann, D. Bottke, J. Faehndrich, and et al. Salvage radiotherapy after prostatectomy - what is the best time to treat? Radiother Oncol 103 2012 239 243
22. A. Briganti, T. Wiegel, S. Joniau, and et al. Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis Eur Urol 62 2012 472 487
23. S.J. Freedland, E.B. Humphreys, L.A. Mangold, and et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy JAMA 294 2005 433 439
24. C.R. King The timing of salvage radiotherapy after radical prostatectomy: a systematic review Int J Radiat Oncol Biol Phys 84 2012 104 111